Mylab Discovery Solutions

Home
India
Pune
Mylab Discovery Solutions

Mylab is health-tech company that develops & commercializes kits & instruments for Reliable answers.

19/06/2025

World Sickle Cell Day | June 19
Every Cell Counts. Every Life Matters.

Today, we stand in solidarity with millions across the globe living with Sickle Cell Disease (SCD)—a lifelong blood disorder that demands more awareness, early diagnosis, and equitable care.

At Mylab, we are committed to advancing early detection and precision diagnostics because timely intervention can transform lives. Sickle Cell Disease is not just a genetic condition—it is a public health priority.

Join us in raising awareness, supporting families, and advocating for innovation in hemoglobinopathy screening and disease management.

14/06/2025

This World Blood Donor Day, we celebrate not just the act of donating blood—but the safety behind every drop.
At Mylab, we’re proud to power safe transfusions with advanced NAT testing, with NATSpert, because behind every drop lies a promise — of trust, of safety, of life.

07/05/2025

Mylab’s groundbreaking tools to support the National Tuberculosis Elimination Program (NTEP), also endorsed by The Central TB Division (CTD).

The Mylab PathoDetect® Mycobacterium Tuberculosis (MTB-MDR) Detection Kit and the Mylab Compact Series – Automation System for molecular diagnostics.

Mylab PathoDetect® MTB-MDR Detection Kit:
• High Sensitivity and Specificity: Mylab kit leverages molecular targets, ensuring superior accuracy and rapid turnaround times, for TB-MDR detection and 1st line drug resistance making testing and treatment initiation much faster
• Single Test MDR Detection: The kit enables rapid detection of MTB complex and simultaneous identification of Rifampicin and Isoniazid resistance directly from patient samples in a single test.
• User-Friendly Workflow: The system minimizes the need for highly trained personnel through simplified workflows, significantly reducing hands-on time and easing the burden on laboratory staff.
• Affordable and Scalable: Designed to make molecular diagnostics accessible to public health programs across diverse geographies.

Mylab’s Compact Series of Instrument:
• Compact, Portable Design: Ideal for all settings, low-medium-high throughput labs.
• Plug-and-Play Installation: Can detect TB and resistance to Rifampicin and Isoniazid, with on just a tabletop
• Highly Mobile and on the go: The system is capable of being used in mobile labs/vans for near patient and field use with testing mechanism requiring minimal specialized skills.
• Digitally enabled: The system is capable of live-tracking and with linkage to any LIMS/HIMS/Nikshay portal.

25/04/2025

At Mylab, we celebrate DNA Day not just as a molecule concept, but as the foundation of everything we do — from early disease detection to developing life-saving diagnostics that empower clinicians and improve patient outcomes.

DNA is more than just a biological blueprint. It’s the common thread that connects innovation in science to real-world impact in healthcare.

On this World DNA Day, we reaffirm our commitment to advancing precision diagnostics and making genomic technologies more accessible, affordable, and actionable.

Here’s to the double helix that continues to inspire breakthroughs.

#

24/04/2025

A major milestone for women’s healthcare in India — Union Minister Dr. Jitendra Singh today launched indigenously developed High Risk HPV test kits for cervical cancer screening.
Mylab Discovery Solutions proudly presented at the forefront of this breakthrough, with its PathoDetectTM High Risk HPV DNA kit validated through multicentric trial with the GCI-BIRAC-DBT initiative. Designed for Mylab’s automated “Compact” platform, the kit offers rapid, reliable, and affordable cervical cancer screening, especially in underserved areas.
This innovation represents a pivotal advancement in democratizing healthcare, enabling early detection, and fostering self-reliance in diagnostics — a transformative milestone in India’s mission to eliminate cervical cancer.

09/04/2025

Cy-TB combines the accuracy of Interferon-Gamma Release Assays (IGRAs) with the simplicity of traditional Tuberculin Skin Tests (TSTs). This innovative test addresses critical challenges in latent TB detection.

• BCG Vaccination Status Independence: Cy-TB overcomes false positives commonly associated with prior BCG vaccinations.
• Field-Friendly Administration: Utilizing the widely recognized Mantoux technique, Cy-TB can be administered in diverse settings without the need for specialized laboratory infrastructure.
• Enhanced Programmatic Implementation: The test features convenient multi-dose vials and is designed for seamless integration into public health initiatives.

With approximately 40% of Indians harboring latent TB infections, the integration of Cy-TB into NTEP represents a significant advancement toward achieving India’s ambitious goal of eliminating TB.

02/04/2025

Revolutionizing TB Detection with Handheld X-ray Technology
Tuberculosis (TB) remains a leading global killer, hitting underserved communities hardest. Early detection is vital, but limited diagnostic access remains a major hurdle.

Enter handheld X-ray technology—a game changer in community-level TB screening.
Portable, battery-operated, and equipped with ML-driven image analysis, these devices are designed to bring diagnostics directly to the field.

Imagine healthcare workers conducting chest X-rays in rural villages, refugee camps, or high-risk occupational settings—without the need for heavy equipment or radiology labs.

• Rapid, point-of-care TB detection
• Increased reach in hard-to-access geographies
• Faster treatment initiation, reducing transmission risk
• Support for national and global TB elimination programs

At the intersection of medical imaging, and public health, handheld X-ray devices symbolize innovation with a purpose—saving lives by making early detection accessible to all.

The future of TB control is mobile, intelligent, and inclusive.

24/03/2025

This World TB Day, we stand united with global healthcare champions in the fight to end Tuberculosis.

TB remains one of the deadliest infectious diseases worldwide. The rise of Multi-Drug Resistant TB (MDR-TB) further challenges treatment outcomes, increases costs and threatens lives. Early detection of drug resistance is not optional — it is critical.

Mylab is committed to empowering healthcare providers with next-generation diagnostics that enable rapid and accurate detection. PathoDetect our fully automated molecular diagnostic system, delivers comprehensive results in a single run—identifying Mycobacterium tuberculosis (MTB) and detecting resistance to Rifampicin and Isoniazid simultaneously.

Because when detection is timely, treatment is effective. Together.

Why PathoDetect is a Game-Changer:
• Detects Drug resistance-TB early, guiding treatment decisions
• Automated sample-to-result workflow minimizes human error
• Fast reporting with minimal hands-on time
• Scalable for public health labs and decentralized settings

Fighting TB today means staying ahead of resistance tomorrow.
Together, Yes We Will End TB — with speed, precision, and technology.

21/03/2025

Experience faster turnaround, reduced operational costs, and seamless integration — all in one powerful platform transforming your diagnostics workflow with Compact DX – your smart solution for high-volume, automated molecular testing.
• Eliminate exhaustive repetitive manual steps
• Maximize accuracy, eliminate human errors,
• Scale up testing without scaling up workload
• Compact design, Big performance
Compact DX – because your lab deserves efficiency, precision, and peace of mind.

12/03/2025

Big diagnostics, small box! Say hello to MyBox.
Your portable, lab-quality Dry Luminescence/Fluorescence analyzer, delivering rapid and reliable results in minutes. No waiting, no hassle—just smart, seamless testing anytime, anywhere. Designed for portability, accuracy, and effortless use, MyBox brings point-of-care testing to your fingertips.

26/02/2025

NATSpert by Mylab for Safe Blood, Every Time, Everywhere –
Precision, Speed & Confidence in Blood Safety for Transfusion

Redefining Blood Testing with NATSpert, Mylab’s next-gen solution designed for highly sensitive, super easy, and automated Blood-borne disease detection.

Key Benefits:
• ID Testing – Individual Donor testing assures the most reliable and safe results
• Multiplex Detection and Discrimination simultaneously – Test for multiple pathogens in a single run, without compromising Sensitivity. Providing safe results every time.
• Ultra-accurate results with advanced molecular technology by Mylab
• Fast & automated workflow for seamless lab efficiency
• Compact, user-friendly design for all lab sizes

NATSpert is setting new standards for blood safety.
Ready to experience next-level precision, write to us info@mylabglobal.com to learn more

20/02/2025

Mylab offers advanced molecular solutions for TB detection, including Compact DX for accurate & assured results, and automated testing with drug resistance analysis for Rifampicin & Isoniazid in the same test. Mylab's portable and point-of-care diagnostics approach enables early and accurate detection, supporting public health initiatives for effective TB control.

Address

Plot No. 99-B, Lonavla Industrial Co-operative Estate Ltd. , Nangargaon, Lonavala 410401
Pune
PLOTNO.99-B,LONAVLAINDUSTRIALCO-OPERATIVEESTATELTD.,NANGARGAON,LONAVALA,MAHARASH

Website

https://mylabglobal.com/

Alerts

Be the first to know and let us send you an email when Mylab Discovery Solutions posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to Mylab Discovery Solutions:

Shortcuts

Want your practice to be the top-listed Clinic in Pune?